[1] |
Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis[J]. J Am Acad Dermatol, 2014,70(2):338⁃351. doi: 10.1016/j.jaad.2013.10.010.
|
[2] |
中华医学会, 中华医学会杂志社, 中华医学会皮肤性病学分会, 等. 儿童特应性皮炎基层诊疗指南(2023年)[J]. 中华全科医师杂志, 2023,22(1):8⁃18. doi: 10.3760/cma.j.cn114798⁃20220915⁃00924.
|
[3] |
顾恒, 尤立平, 刘永生, 等. 我国10城市学龄前儿童特应性皮炎现况调查[J]. 中华皮肤科杂志, 2004,37(1):29⁃31. doi: 10.3760/j.issn:0412⁃4030.2004.01.011.
|
[4] |
Guo Y, Li P, Tang J, et al. Prevalence of atopic dermatitis in Chinese children aged 1⁃7 ys[J]. Sci Rep, 2016,6:29751. doi: 10.1038/srep29751.
|
[5] |
Guo Y, Zhang H, Liu Q, et al. Phenotypic analysis of atopic dermatitis in children aged 1⁃12 months: elaboration of novel diagnostic criteria for infants in China and estimation of prevalence[J]. J Eur Acad Dermatol Venereol, 2019,33(8):1569⁃1576. doi: 10.1111/jdv.15618.
|
[6] |
Cheng R, Zhang H, Zong W, et al. Development and validation of new diagnostic criteria for atopic dermatitis in children of China[J]. J Eur Acad Dermatol Venereol, 2020,34(3):542⁃548. doi: 10.1111/jdv.15979.
|
[7] |
Liu P, Zhao Y, Mu ZL, et al. Clinical features of adult/adolescent atopic dermatitis and Chinese criteria for atopic dermatitis[J]. Chin Med J (Engl), 2016,129(7):757⁃762. doi: 10.4103/0366⁃6999.178960.
|
[8] |
中华医学会皮肤性病学分会, 中国医师协会皮肤科医师分会. 中国中重度特应性皮炎诊疗临床路径专家共识(2023版)[J]. 中华皮肤科杂志, 2023,56(11):1000⁃1007. doi: 10. 35541/cjd.20230247.
|
[9] |
Esenboğa S, Şekerel BE, Tezcan İ. Primary immunodeficiencies associated with atopic dermatitis[J]. Asthma Allergy Immunol, 2019,17(2):70⁃77. doi: 10.21911/aai.423.
|
[10] |
中华医学会皮肤性病学分会免疫学组. 特应性皮炎的全程管理共识[J]. 中华皮肤科杂志, 2023,56(1):5⁃15. doi: 10.35541/cjd.20220618.
|
[11] |
田晶, 申春平, 马琳. 患者治疗教育在儿童特应性皮炎长期治疗管理中的作用[J]. 中国皮肤性病学杂志, 2016,30(7):691⁃694. doi: 10.13735/j.cjdv.1001⁃7089.201511102.
|
[12] |
Takaoka R, Coelho E. Patient education in atopic dermatitis: why it is needed and how to improve it[J]. Curr Dermatol Rep, 2018,7:221⁃226. doi: 10.1007/s13671⁃018⁃0241⁃x.
|
[13] |
Sidbury R, Tom WL, Bergman JN, et al. Guidelines of care for the management of atopic dermatitis: section 4. Prevention of disease flares and use of adjunctive therapies and approaches[J]. J Am Acad Dermatol, 2014,71(6):1218⁃1233. doi: 10.1016/j.jaad.2014.08.038.
|
[14] |
Wilken B, Zaman M, Asai Y. Patient education in atopic dermatitis: a scoping review[J]. Allergy Asthma Clin Immunol, 2023,19(1):89. doi: 10.1186/s13223⁃023⁃00844⁃w.
|
[15] |
Weber MB, Fontes Neto Pde T, Prati C, et al. Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups[J]. J Eur Acad Dermatol Venereol, 2008,22(8):992⁃997. doi: 10.1111/j.1468⁃3083.2008.02697.x.
|
[16] |
中华医学会皮肤性病学分会免疫学组, 特应性皮炎协作研究中心. 中国特应性皮炎诊疗指南(2020版)[J]. 中华皮肤科杂志, 2020,53(2):81⁃88. doi: 10.35541/cjd.20191000.
|
[17] |
AAAAI/ACAAI JTF Atopic Dermatitis Guideline Panel, Chu DK, et al. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE⁃ and Institute of Medicine⁃based recommendations[J]. Ann Allergy Asthma Immunol, 2024,132(3):274⁃312. doi: 10.1016/j.anai.2023.11. 009.
|
[18] |
Geba GP, Li D, Xu M, et al. Attenuating the atopic march: meta⁃analysis of the dupilumab atopic dermatitis database for incident allergic events[J]. J Allergy Clin Immunol, 2023,151(3):756⁃766. doi: 10.1016/j.jaci.2022.08.026.
|
[19] |
Thyssen JP, Corn G, Wohlfahrt J, et al. Retrospective markers of paediatric atopic dermatitis persistence after hospital diagnosis: a nationwide cohort study[J]. Clin Exp Allergy, 2019,49(11):1455⁃1463. doi: 10.1111/cea.13487.
|
[20] |
中国中西医结合学会皮肤性病专业委员会环境与职业性皮肤病学组, 中华医学会皮肤性病学分会儿童学组, 中国老年保健医学研究会皮肤科分会. 特应性皮炎外用制剂合理应用及患者指导专家共识[J]. 中华皮肤科杂志, 2022,55(4):281⁃288. doi: 10.35541/cjd.20210833.
|
[21] |
栾婷婷, 彭承悦, 宋晓婷, 等. 中文版特应性皮炎控制工具的信效度与反应度的验证性研究[J]. 中华预防医学杂志, 2023,57(3):422⁃426. doi: 10.3760/cma.j.cn112150⁃20221019⁃01007.
|